Participants 243 282 6
patients with moderate-to-severe asthma
Participants 559 598 4
patients with moderate-to-severe asthma
Participants 884 1003 4
Symptomatic patients (n = 428) with FEV1 of 50-85% predicted and increased symptom scores or reliever use during run-in
